NCT05121441View on ClinicalTrials.gov

Study to Evaluate ARD-101 in Adults With Obesity

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

November 9, 2022

Study Completion Date

November 9, 2022

Conditions
Obesity
Interventions
DRUG

ARD-101

Twice daily, oral administration

DRUG

Placebo

Twice daily, oral administration

Trial Locations (1)

92037

Altman Clinical and Translational Research Institute, University of California, San Diego, San Diego

Sponsors
All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

Aardvark Therapeutics, Inc.

INDUSTRY